[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $rgnx REGENXBIO's stock is seeing mixed reactions as the company completes enrollment in pivotal trials while facing an FDA review extension. Positive social engagement is present, but investor uncertainty remains. ### About $rgnx REGENXBIO Inc. (RGNX) is a biotechnology company focused on the development of gene therapies. ### Engagements: XXXXX [#](/topic/$rgnx/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$rgnx/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXX +18% **1-Year High**: XXXXXX on 2025-05-12 **1-Year Low**: XX on 2025-09-30 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XX [#](/topic/$rgnx/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$rgnx/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-09-15 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: XX [#](/topic/$rgnx/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$rgnx/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $rgnx in the last XX hours which is up XXXX% from XX in the previous XX hours **Daily Average**: XX **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-09-19 The most influential creators that mention $rgnx in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | X | XXXXX | X | XXXXX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XXX | | [@RogueAnalysta](/creator/twitter/RogueAnalysta) | X | XX | X | XXX | | [@BRSreality](/creator/twitter/BRSreality) | X | XXX | X | XX | | [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X | XXXXX | X | XX | | [@Brad_E_Schulz](/creator/twitter/Brad_E_Schulz) | X | XXXXXX | X | XX | | [@Bio_Scout](/creator/twitter/Bio_Scout) | X | XXX | X | XX | | [@mike98572986](/creator/twitter/mike98572986) | X | XXX | X | X | [View More](/list/creators/$rgnx/100) ### Sentiment: XX% [#](/topic/$rgnx/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$rgnx/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% no change **1 Month**: XX% -XX% **1-Year High**: XXX% on 2025-04-27 **1-Year Low**: XX% on 2025-09-11 **Most Supportive Themes** - **Positive Clinical Trial Data and Presentations:** (40%) Positive news regarding clinical trial data and upcoming presentations is driving positive sentiment. - **Analyst Reports and Recommendations:** (30%) Reports from analysts, particularly those from major financial institutions, are highlighting positive aspects of the company. - **Mentions in Broader Biotech Discussions:** (20%) The stock is being mentioned in discussions about the biotech sector, often alongside other promising companies. **Most Critical Themes** - **FDA Review Extension:** (10%) The FDA review extension for RGX-121 raises some concerns, despite no safety issues being reported. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XX | X% | XXXXX | XX% | XX | X% | | | | | | | | | | Total | XX | X% | XXXXX | XX% | XX | X% | **Top assets mentioned** In the posts about $rgnx in the last XX hours [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [uniQure N.V. (QURE)](/topic/$qure) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Advanced Micro Devices (AMD)](/topic/advanced-micro-devices) [AbbVie Inc (ABBV)](/topic/$abbv) [BEAM (BEAM)](/topic/$beam) [Bitcoin Incognito (XBI)](/topic/$xbi) [Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc) **Top topics mentioned** In the posts about $rgnx in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [coins defi](/topic/coins-defi), [investment](/topic/investment), [telegram](/topic/telegram), [coins dao](/topic/coins-dao), [stocks](/topic/stocks), [$ntla](/topic/$ntla), [$qure](/topic/$qure), [$bmrn](/topic/$bmrn), [advanced micro devices](/topic/advanced-micro-devices), [stocks technology](/topic/stocks-technology), [$abbv](/topic/$abbv), [$beam](/topic/$beam), [$clpt](/topic/$clpt), [$xbi](/topic/$xbi), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$clsd](/topic/$clsd), [$crsp](/topic/$crsp), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$4516t](/topic/$4516t), [$iova](/topic/$iova), [$incy](/topic/$incy), [$mrna](/topic/$mrna), [$blue](/topic/$blue), [$kymr](/topic/$kymr), [$ibb](/topic/$ibb), [coins solana ecosystem](/topic/coins-solana-ecosystem), [brad](/topic/brad), [$bmy](/topic/$bmy), [superrarebears](/topic/superrarebears), [$sldb](/topic/$sldb), [$sgmo](/topic/$sgmo), [$srpt](/topic/$srpt), [$200m](/topic/$200m), [$150m](/topic/$150m), [$110m](/topic/$110m), [money](/topic/money), [launches](/topic/launches), [$trda](/topic/$trda), [$308k](/topic/$308k), [$131k](/topic/$131k), [$291k](/topic/$291k), [$18k](/topic/$18k), [sec](/topic/sec), [monaco](/topic/monaco), [$glue](/topic/$glue), [$apvo](/topic/$apvo), [$caba](/topic/$caba), [$autl](/topic/$autl), [$fate](/topic/$fate), [$fold](/topic/$fold), [$zyme](/topic/$zyme), [$kura](/topic/$kura), [united states](/topic/united-states), [$tsha](/topic/$tsha), [bank of america](/topic/bank-of-america), [$labu](/topic/$labu), [$sdgr](/topic/$sdgr), [dyne therapeutics](/topic/dyne-therapeutics), [breakthrough](/topic/breakthrough), [$dyn](/topic/$dyn), [$ngne](/topic/$ngne), [$crml](/topic/$crml), [$cenx](/topic/$cenx), [$ag](/topic/$ag), [$uamy](/topic/$uamy), [$rpid](/topic/$rpid), [$tmdx](/topic/$tmdx), [$meli](/topic/$meli), [$zbio](/topic/$zbio), [$apge](/topic/$apge), [$dna](/topic/$dna), [$pfe](/topic/$pfe), [$bynd](/topic/$bynd), [$bkng](/topic/$bkng), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$mstr](/topic/$mstr), [coins bsc](/topic/coins-bsc), [$arry](/topic/$arry), [$spwr](/topic/$spwr), [$sedg](/topic/$sedg), [$absi](/topic/$absi), [$rxrx](/topic/$rxrx), [$amgn](/topic/$amgn), [$ions](/topic/$ions), [$cytk](/topic/$cytk), [$arwr](/topic/$arwr), [superrare](/topic/superrare), [$254k](/topic/$254k), [$dnli](/topic/$dnli), [$flex](/topic/$flex), [coins exchange tokens](/topic/coins-exchange-tokens), [flex flex](/topic/flex-flex), [$tgen](/topic/$tgen), [$eps](/topic/$eps), [$plrx](/topic/$plrx), [$icpt](/topic/$icpt), [$ocul](/topic/$ocul), [$eypt](/topic/$eypt), [$asst](/topic/$asst) ### Top Social Posts [#](/topic/$rgnx/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$RGNX upcoming significant events: 1) RGX-121 for Hunter Syndrome FDA PDUFA date Feb X '26 2)RGX-202 Douchenne Muscular Dystrophy: Pivotal trial data in 1H '26 BLA submission in mid '26. 3) ABBV-RGX-314 for Retinal Disease Pivotal top line data in Q4 '26" [X Link](https://x.com/C1_dF9432/status/1978626922381807685) [@C1_dF9432](/creator/x/C1_dF9432) 2025-10-16T00:59Z 1128 followers, XXX engagements "Replay and Transcript: Barclays Call with LEGN Senior Management Post JNJ Earnings Full report in Telegram (in bio)👆 $LEGN $JNJ $AMGN $BMRN $VRTX $SRPT $IONS $ALNY $ARWR $BLUE $CRSP $EDIT $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD" [X Link](https://x.com/Biobeats99/status/1978596172886315471) [@Biobeats99](/creator/x/Biobeats99) 2025-10-15T22:57Z XXX followers, XXX engagements "Quite some weakness in the recent high-flyers like drones (no pun intended) and rare earths. On the other hand some semis groups looking strong - namely datacenter buildout ( $FLEX $TGEN $POWL ) and memory ( $WDC $MU )" [X Link](https://x.com/RogueAnalysta/status/1978564830664548821) [@RogueAnalysta](/creator/x/RogueAnalysta) 2025-10-15T20:53Z XX followers, XXX engagements "$RGNX #events 🦉 REGENXBIO $RGNX to present at Chardan Guggenheim and Stifel healthcare conferences spotlighting its gene therapy programs in CNS and muscular dystrophies" [X Link](https://x.com/AponiaAnalytics/status/1978536871425642798) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-10-15T19:02Z 5207 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$rgnx
REGENXBIO's stock is seeing mixed reactions as the company completes enrollment in pivotal trials while facing an FDA review extension. Positive social engagement is present, but investor uncertainty remains.
About $rgnx
REGENXBIO Inc. (RGNX) is a biotechnology company focused on the development of gene therapies.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX +18%
1-Year High: XXXXXX on 2025-05-12
1-Year Low: XX on 2025-09-30
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-15
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $rgnx in the last XX hours which is up XXXX% from XX in the previous XX hours
Daily Average: XX
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-19
The most influential creators that mention $rgnx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiotechAnalysst | X | XXXXX | X | XXXXX |
| @Biobeats99 | X | XXX | X | XXX |
| @RogueAnalysta | X | XX | X | XXX |
| @BRSreality | X | XXX | X | XX |
| @AponiaAnalytics | X | XXXXX | X | XX |
| @Brad_E_Schulz | X | XXXXXX | X | XX |
| @Bio_Scout | X | XXX | X | XX |
| @mike98572986 | X | XXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-11
Most Supportive Themes
- Positive Clinical Trial Data and Presentations: (40%) Positive news regarding clinical trial data and upcoming presentations is driving positive sentiment.
- Analyst Reports and Recommendations: (30%) Reports from analysts, particularly those from major financial institutions, are highlighting positive aspects of the company.
- Mentions in Broader Biotech Discussions: (20%) The stock is being mentioned in discussions about the biotech sector, often alongside other promising companies.
Most Critical Themes
- FDA Review Extension: (10%) The FDA review extension for RGX-121 raises some concerns, despite no safety issues being reported.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XXXXX | XX% | XX | X% |
| Total | XX | X% | XXXXX | XX% | XX | X% |
Top assets mentioned In the posts about $rgnx in the last XX hours
Intellia Therapeutics, Inc (NTLA) uniQure N.V. (QURE) BioMarin Pharmaceutical, Inc. (BMRN) Advanced Micro Devices (AMD) AbbVie Inc (ABBV) BEAM (BEAM) Bitcoin Incognito (XBI) Sarepta Therapeutics, Inc. (SRPT) CRISPR Therapeutics AG (CRSP) Regeneron Pharmaceuticals Inc (REGN)
Top topics mentioned In the posts about $rgnx in the last XX hours
stocks healthcare, coins defi, investment, telegram, coins dao, stocks, $ntla, $qure, $bmrn, advanced micro devices, stocks technology, $abbv, $beam, $clpt, $xbi, sarepta therapeutics inc, $clsd, $crsp, regeneron pharmaceuticals inc, $4516t, $iova, $incy, $mrna, $blue, $kymr, $ibb, coins solana ecosystem, brad, $bmy, superrarebears, $sldb, $sgmo, $srpt, $200m, $150m, $110m, money, launches, $trda, $308k, $131k, $291k, $18k, sec, monaco, $glue, $apvo, $caba, $autl, $fate, $fold, $zyme, $kura, united states, $tsha, bank of america, $labu, $sdgr, dyne therapeutics, breakthrough, $dyn, $ngne, $crml, $cenx, $ag, $uamy, $rpid, $tmdx, $meli, $zbio, $apge, $dna, $pfe, $bynd, $bkng, stocks consumer cyclical, $mstr, coins bsc, $arry, $spwr, $sedg, $absi, $rxrx, $amgn, $ions, $cytk, $arwr, superrare, $254k, $dnli, $flex, coins exchange tokens, flex flex, $tgen, $eps, $plrx, $icpt, $ocul, $eypt, $asst
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RGNX upcoming significant events: 1) RGX-121 for Hunter Syndrome FDA PDUFA date Feb X '26 2)RGX-202 Douchenne Muscular Dystrophy: Pivotal trial data in 1H '26 BLA submission in mid '26. 3) ABBV-RGX-314 for Retinal Disease Pivotal top line data in Q4 '26"
X Link @C1_dF9432 2025-10-16T00:59Z 1128 followers, XXX engagements
"Replay and Transcript: Barclays Call with LEGN Senior Management Post JNJ Earnings Full report in Telegram (in bio)👆 $LEGN $JNJ $AMGN $BMRN $VRTX $SRPT $IONS $ALNY $ARWR $BLUE $CRSP $EDIT $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD"
X Link @Biobeats99 2025-10-15T22:57Z XXX followers, XXX engagements
"Quite some weakness in the recent high-flyers like drones (no pun intended) and rare earths. On the other hand some semis groups looking strong - namely datacenter buildout ( $FLEX $TGEN $POWL ) and memory ( $WDC $MU )"
X Link @RogueAnalysta 2025-10-15T20:53Z XX followers, XXX engagements
"$RGNX #events 🦉 REGENXBIO $RGNX to present at Chardan Guggenheim and Stifel healthcare conferences spotlighting its gene therapy programs in CNS and muscular dystrophies"
X Link @AponiaAnalytics 2025-10-15T19:02Z 5207 followers, XX engagements